Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Furuta (WakayamaCity, Japan), D. Fujimoto (WakayamaCity, Japan), A. Matsunashi (KobeCity, Japan), M. Tanaka (WakayamaCity, Japan), R. Shibaki (WakayamaCity, Japan), Y. Shimada (KobeCity, Japan), K. Nagata (KobeCity, Japan), K. Tomii (KobeCity, Japan), N. Yamamoto (WakayamaCity, Japan). Clinical course and outcomes of acute exacerbation of fibrosing interstitial lung disease. 2241

Member's Comments

No comment yet.

Related content which might interest you: Clinical features of acute exacerbation in chronic birdfancier‘s lung Source: Eur Respir J 2006; 28: Suppl. 50, 675s Year: 2006 Clinical predictors and explant lung pathology of acute exacerbation of idiopathic pulmonary fibrosis Source: ERJ Open Res, 6 (4) 00261-2019; 10.1183/23120541.00261-2019 Year: 2020 Clinical features of pulmonary aspergillosis in patients with chronic fibrosing interstitial pneumonia Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease Year: 2010 Acute exacerbation of idiopathic pulmonary fibrosis as the initial presentation of the disease Source: Eur Respir Rev 2009; 18: 129-132 Year: 2009 Clinical features and outcome of patients with acute exacerbation of interstitial pneumonia associated with collagen vascular disease Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010 Difference of the clinical characteristics and outcome between interstitial lung disease with dermatomyositis and idiopathic interstitial pneumonia Source: International Congress 2017 – Lung function testing Year: 2017 Acute exacerbations of interstitial lung disease Source: Eur Respir Monogr 2016; 74: 117-131 Year: 2016 A large cohort study of clinical outcomes and prognostic predictors in patients with acute exacerbation of idiopathic pulmonary fibrosis Source: International Congress 2014 – IPF and surroundings Year: 2014 Acute exacerbation admissions of fibrosing interstitial lung diseases – 3 years study Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases Year: 2019 A proof of concept study by thrombomodulin for acute exacerbations of idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Clinical experience with nintedanib for the treatment of IPF in 80 cases Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Clinical efficacy of pirfenidone in patients with severe fibrosing interstitial pneumonia Source: International Congress 2015 – Treatment of IPF Year: 2015 Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia Source: Eur Respir J 2009; 33: 68-76 Year: 2009 Interstitial lung disease Source: Eur Respir Rev 2013; 22: 26-32 Year: 2013 Survival after respiratory hospitalization in patients with idiopathic chronic fibrosing interstitial pneumonia Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias? Year: 2018 Clinical impact of an interstitial lung disease Nurse on patients with idiopathic pulmonary fibrosis Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias? Year: 2018 Clinical features and predictive factors for acute exacerbation of idiopathic pulmonary fibrosis Source: Annual Congress 2007 - Clinical aspects of idiopathic pulmonary fibrosis Year: 2007 Different characteristics and outcomes of acute exacerbation: comparison between interstitial pneumonia with autoimmune features and lone idiopathic interstitial pneumonia. Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias Year: 2018 Differences of acute exacerbations in idiopathic pulmonary fibrosis compared to other fibrotic lung diseases Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis Year: 2019 Clinical features of chronic pulmonary aspergillosis in patients with interstitial pneumonia Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas Year: 2010